Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
17°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Microbot Medical Inc.
< Previous
1
2
Next >
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
October 15, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
September 30, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
September 17, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
August 22, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
August 13, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
August 01, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
July 18, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
July 09, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
July 08, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
July 03, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
June 20, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
June 17, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 04, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 03, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
June 03, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
April 29, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Shares Status Following Recent Geopolitical Events
April 15, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
February 05, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
January 30, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study
January 18, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
December 29, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met
December 28, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic
December 14, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study
December 07, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities
November 21, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process
November 13, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office
November 08, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study
October 31, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024
October 24, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company
October 19, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.